Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_assertion type Assertion NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_head.
- NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_assertion description "[We have analysed, by in situ hybridization, mRNA expression of TGF-beta 1, TGF-beta 2, TGF-beta 3, and of TGF-beta type II receptor in benign melanocytic naevi, primary melanomas, and in skin metastases of malignant melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_provenance.
- NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_assertion evidence source_evidence_literature NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_provenance.
- NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_assertion SIO_000772 7614683 NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_provenance.
- NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_assertion wasDerivedFrom befree-20140225 NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_provenance.
- NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_assertion wasGeneratedBy ECO_0000203 NP708084.RA593irfMV_wW8-Wr-bqmGM_J_cPvd1_EGfGUvfF8Hpao130_provenance.